contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


monsenso-adjusts-the-expectations-for-2023-and-issues-guidance-for-2024

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Monsenso operates in the IT sector. The company specializes in the provision of digital follow-up systems for care and nursing, as well as hospitals. The solutions are software-based and are mainly used for monitoring patients' health, as well as for internal monitoring and analysis. The largest operations are in the Nordic market. The head office is located in Copenhagen.

Monsenso

27.2.2024 10:50:14 CET | Monsenso | Company AnnouncementCompany announcement no. 03-2024Copenhagen, 2024.02.27“This message includes inside information”Monsenso expects the revenue for 2023 ...

27.2.2024 10:50:14 CET | Monsenso | Company AnnouncementCompany announcement no. 03-2024Copenhagen, 2024.02.27“This message includes inside information”Monsenso expects the revenue for 2023 to amount to DKK 9.6m and the EBITDA to amount to DKK -1.4m.Guidance for the year was revenue of DKK 10-11m and EBITDA DKK -3m to -2m.The expected revenue is at the low end of the guidance interval, whereas the EBITDA is significantly better than previously expected. The revenue has grown 55% year-over-year, which is a result of impressive efforts during 2023.The revenue expectations for the year 2024 are DKK 11-13m with an EBITDA of -1,5m to -3,0m.The main goal for 2024 is to increase our revenue. Over the past few years, we have strengthened our digital health platform to meet the requirements necessary for expanding our market presence. Therefore, we expect to invest more in sales and marketing activities in particularly Denmark, the UK and German-speaking countries in 2024.The annual report for 2023 will be issued on March 6, 2024.Further information:MonsensoCEO Thomas Lethenborg Tel. +45 21 29 88 27 E-mail:&nbsp;<a href="mailto:lethenborg@monsenso.com">lethenborg@monsenso.com</a>&nbsp;Chairman of the board Peter Mørch Eriksen Tel. +45 51 99 66 00 E-mail:&nbsp;<a href="mailto:Petermorcheriksen@outlook.com">Petermorcheriksen@outlook.com</a>Certified AdviserNorden CEF A/S John NordenE-mail:&nbsp;<a href="mailto:jn@nordencef.dk">jn@nordencef.dk</a><h4>About Monsenso</h4>Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence and behavioral data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. We collaborate with health and social care, pharmaceuticals and leading researcher worldwide in our endeavors to deliver solutions that fit into the lives of patients and health care professionals. To learn more visit <a href="http://www.monsenso.com">www.monsenso.com</a><h4>Attachments</h4><ul> <li> <a href="https://via.ritzau.dk/ir-files/13559904/8237/12724/Download%20announcement%20as%20PDF.pdf">Download announcement as PDF.pdf</a> </li></ul>

Monsenso adjusts the expectations for 2023 and issues guidance for  2024

Return on capital (ROE, ROI, ROIC, RONIC)

What does negative working capital mean and why is it a good thing?

Amazon and Costco in Sweden: A looming threat that Nordic retailers ignore at their peril

Global bull market

Amazon continues to grow in Sweden

About Monsenso

Attachments

Stay up to date with our newsletter